NORTH AMERICA BIOCHIPS MARKET 2019-2027

1.    BIOCHIPS MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.3. EVOLUTION & TRANSITION OF BIOCHIPS

2.4. PORTER'S FIVE FORCE ANALYSIS

2.5. MARKET ATTRACTIVENESS MATRIX

2.6. INDUSTRY COMPONENTS

2.7. REGULATORY FRAMEWORK

2.8. VENDOR SCORECARD

2.9. KEY IMPACT ANALYSIS

2.10.            MARKET OPPORTUNITY INSIGHTS

2.11.            INDUSTRY PLAYER POSITIONING

2.12.            KEY MARKET STRATEGIES

2.13.            MARKET DRIVERS

2.13.1.                GROWTH IN PERSONALIZED MEDICINES

2.13.2.                RISING INCIDENCES & TREATMENT OF CANCER

2.13.3.                CONSTANT RISE IN HEALTHCARE SPENDING WORLDWIDE

2.13.4.                INCREASING NUMBER OF INVESTMENTS IN BIOTECHNOLOGY R&D

2.14.            MARKET RESTRAINTS

2.14.1.                INEQUALITY IN HEALTHCARE ACCESS

2.14.2.                INADEQUATE TECHNICAL AWARENESS RELATED TO BIOCHIPS

2.14.3.                COMPLEXITY OF BIOLOGICAL SYSTEMS

2.15.            MARKET OPPORTUNITIES

2.15.1.                DEVELOPMENTS IN BIOCHIPS TECHNOLOGY

2.15.2.                WIDENING APPLICATION AREAS OF BIOCHIPS

2.16.            MARKET CHALLENGES

2.16.1.                AVAILABILITY OF SUBSTITUTE TECHNOLOGIES

2.16.2.                UNCLEAR REGULATORY GUIDELINES

2.16.3.                COST CONSTRAINTS

3.    BIOCHIPS INDUSTRY OUTLOOK – BY TYPE

3.1. DNA CHIPS

3.1.1.   AGRICULTURAL BIOTECHNOLOGY

3.1.2.   CANCER DIAGNOSTICS & TREATMENT

3.1.3.   DRUG DISCOVERY

3.1.4.   GENE EXPRESSION

3.1.5.   GENOMICS

3.1.6.   SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING

3.1.7.   OTHER DNA CHIPS

3.2. LAB ON A CHIP

3.2.1.   CLINICAL DIAGNOSTICS

3.2.2.   DRUG DISCOVERY

3.2.3.   GENOMICS

3.2.4.   POINT OF CARE & IN VITRO DIAGNOSIS

3.2.5.   PROTEOMICS

3.2.6.   OTHER LAB ON A CHIP

3.3. PROTEIN CHIPS

3.3.1.   DIAGNOSTICS

3.3.2.   DRUG DISCOVERY

3.3.3.   EXPRESSION PROFILING

3.3.4.   HIGH THROUGHPUT SCREENING

3.3.5.   PROTEOMICS

3.3.6.   OTHER PROTEIN CHIPS

3.4. OTHER CHIPS

3.4.1.   CELL ARRAYS

3.4.2.   TISSUE ARRAYS

4.    BIOCHIPS INDUSTRY OUTLOOK - BY SUBSTRATE MATERIAL

4.1. GLASS

4.2. POLYMERS

4.3. SILICON

4.4. OTHER SUBSTRATE MATERIALS

5.    BIOCHIPS INDUSTRY OUTLOOK - BY END USER

5.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES

5.2. HOSPITALS AND DIAGNOSTICS CENTERS

5.3. ACADEMIC AND RESEARCH INSTITUTE

6.    BIOCHIPS INDUSTRY - NORTH AMERICA

6.1. UNITED STATES

6.2. CANADA

7.    COMPETITIVE LANDSCAPE

7.1. AGILENT TECHNOLOGY INC.

7.2. BIOCHAIN INSTITUTE INC.

7.3. BIOMERIEUX SA

7.4. BIO-RAD LABORATORIES INC.

7.5. CEPHEID INC.

7.6. CYBRDI INC.

7.7. FLUIDIGM CORPORATION

7.8. GAMIDA FOR LIFE GROUP

7.9. ILLUMINA INC.

7.10.            IMGENEX

7.11.            MERCK GMBH

7.12.            ORIGENE TECHNOLOGIES INC.

7.13.            PERKINELMER INC.

7.14.            SAMSUNG ELECTRONICS INC.

7.15.            THERMO FISHER SCIENTIFIC INC.

8.    METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

TABLE 1. MARKET ATTRACTIVENESS MATRIX FOR BIOCHIPS MARKET       

TABLE 2. VENDOR SCORECARD OF BIOCHIPS MARKET

TABLE 3. REGULATORY FRAMEWORK OF BIOCHIPS MARKET

TABLE 4. KEY STRATEGIC DEVELOPMENTS IN BIOCHIPS MARKET

TABLE 5. ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN THE UNITED STATES IN 2017    

TABLE 6. NOTABLE INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017          

TABLE 7. ESTIMATED R&D EXPENDITURE IN MEDICAL & HEALTHCARE INDUSTRY OF UNITED STATES, 2013-2015 (IN $ MILLIONS)

TABLE 8. ESTIMATED R&D SPENDING IN BIOTECHNOLOGY, PHARMACEUTICAL, & MEDICAL INDUSTRY OF THE UNITED STATES, 2013-2015 (IN $ MILLIONS)

TABLE 9. NORTH AMERICA BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)

TABLE 10. NORTH AMERICA BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)       

TABLE 11. NORTH AMERICA BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)

TABLE 12. NORTH AMERICA BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)

FIGURE 1. NORTH AMERICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)  

FIGURE 2. PORTER’S FIVE FORCE ANALYSIS OF BIOCHIPS MARKET

FIGURE 3. KEY IMPACT ANALYSIS

FIGURE 4. TIMELINE OF BIOCHIPS

FIGURE 5. MARKET OPPORTUNITY INSIGHTS, BY TYPE, 2018

FIGURE 6. MARKET OPPORTUNITY INSIGHTS, BY END USER, 2018   

FIGURE 7. INDUSTRY COMPONENTS OF BIOCHIPS MARKET   

FIGURE 8. KEY PLAYER POSITIONING IN 2018 (%)

FIGURE 9. UNITED STATES HEALTHCARE SPENDING, 2015-2025 (% OF GDP)        

FIGURE 10. COMPARISON OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE        

FIGURE 11. NORTH AMERICA BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION)           

FIGURE 12. NORTH AMERICA DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION)

FIGURE 13. NORTH AMERICA DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION)

FIGURE 14. NORTH AMERICA DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)      

FIGURE 15. NORTH AMERICA DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION)      

FIGURE 16. NORTH AMERICA DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)      

FIGURE 17. NORTH AMERICA DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN $ MILLION)         

FIGURE 18. NORTH AMERICA DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)      

FIGURE 19. NORTH AMERICA BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION)      

FIGURE 20. NORTH AMERICA LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION)

FIGURE 21. NORTH AMERICA LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)

FIGURE 22. NORTH AMERICA LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)

FIGURE 23. NORTH AMERICA LAB ON A CHIP MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2027 (IN $ MILLION)

FIGURE 24. NORTH AMERICA LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)      

FIGURE 25. NORTH AMERICA LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION)

FIGURE 26. NORTH AMERICA BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 27. NORTH AMERICA PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION)

FIGURE 28. NORTH AMERICA PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)

FIGURE 29. NORTH AMERICA PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION)

FIGURE 30. NORTH AMERICA PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION)

FIGURE 31. NORTH AMERICA PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)

FIGURE 32. NORTH AMERICA PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 33. NORTH AMERICA BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 34. NORTH AMERICA OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION)

FIGURE 35. NORTH AMERICA OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION)

FIGURE 36. NORTH AMERICA BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS)           

FIGURE 37. NORTH AMERICA BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS)

FIGURE 38. NORTH AMERICA BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS)

FIGURE 39. NORTH AMERICA BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)

FIGURE 40. NORTH AMERICA BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2027 (IN $ MILLIONS)

FIGURE 41. NORTH AMERICA BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2027 (IN $ MILLIONS)

FIGURE 42. NORTH AMERICA BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS)

FIGURE 43. NORTH AMERICA BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)           

FIGURE 44. UNITED STATES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 

FIGURE 45. CANADA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)